Free Trial

Spectral Medical (TSE:EDT) Share Price Passes Above 50-Day Moving Average - Time to Sell?

Spectral Medical logo with Medical background

Key Points

  • Spectral Medical Inc. shares have recently crossed above the 50-day moving average, signaling a potential bullish trend, with the last traded price at C$1.48.
  • The company's market cap is C$416.25 million and it reported a PE ratio of -21.14, indicating financial challenges.
  • Spectral Medical focuses on the development of treatments for septic shock, utilizing its endotoxin activity assay (EAA) and toraymyxin therapeutic.
  • MarketBeat previews top five stocks to own in October.

Spectral Medical Inc. (TSE:EDT - Get Free Report)'s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.92 and traded as high as C$1.50. Spectral Medical shares last traded at C$1.48, with a volume of 390,549 shares changing hands.

Spectral Medical Price Performance

The firm has a market capitalization of C$448.74 million, a PE ratio of -22.43 and a beta of -0.18. The company has a fifty day moving average price of C$0.96 and a two-hundred day moving average price of C$0.84. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Further Reading

Should You Invest $1,000 in Spectral Medical Right Now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.